Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
about
CytoJournal's move to the new platform: More on financial model to the support open-access charter in cytopathology, publication quality indicators, and other issuesTissue Harvester with Functional Valve (THFV): Shidham's device for reproducibly higher specimen yield by fine needle aspiration biopsy with easy to perform steps.Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy.Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?The utility of BRAF testing in the management of papillary thyroid cancer.BRAF gene: From human cancers to developmental syndromes.The Best in CytoJournal: 2006.Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis.Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodulesSurgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules.B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules.BRAF mutation testing in clinical practice.Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma.BRAF mutation in fine-needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area.BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis.Minireview: Role of genetic changes of faciogenital dysplasia protein 1 in human disease.RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver.Contribution of the BRAF oncogene in the pre-operative phase of thyroid carcinoma.Cytological and molecular diagnosis of solid variant of papillary thyroid carcinoma: a case reportAssessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.Thank you reviewers- CytoJournal 2007.False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK.Guidelines for the management of thyroid cancer
P2860
Q28754713-C970CFEC-92B1-4ACE-8F41-0525DA73F626Q30479128-E175DCA4-FF14-472E-99D9-34032CD31A46Q34173053-A5AAF06C-8E15-419A-B84F-E3D5E932C85CQ34625948-E607A88F-18BE-4B14-805B-A376B39F7667Q35583821-565D5EA0-B2CF-4EA9-80CA-001971CD9658Q35802430-118D6A14-6BE4-4443-A841-839C90A41508Q35865253-56F86C72-7335-40F6-BF02-CBF70B0586B1Q36172170-2AA092C7-4884-4D4B-9842-AEA1897277C7Q36310205-6C975350-D336-4030-81E8-BA653CCC795BQ37431090-D3635072-06A9-4A4B-A024-E140C0E1B9A4Q37459366-E3E729D2-1EDD-401F-B799-A66F88325389Q37988572-974134EE-84C8-473D-9A52-A6EB670A4191Q38225733-8AD345F7-8438-4C07-B855-F326CA1CF0D1Q38431921-72CA0683-637F-4B28-9BFB-8AB8079C91E6Q38438138-78B86F4D-D100-4F62-B03B-B2CE44AB65D3Q38446252-BF356BCF-D998-4FD8-B20D-7CAE467D720AQ38839147-7FCB0571-A207-4BA9-A9BC-C7CE4F5BAEC5Q39289867-DACEE488-DC10-45E8-995F-A05AEF74100CQ41826094-87325D3D-24D7-4097-80E5-6208FD0E7373Q41893239-4AF8AD2D-9DE8-4806-BA78-94D83D246891Q44297101-45690DAA-F1A5-4F5C-AB9B-E4C770284C22Q45924542-610C82C7-7BEF-4A46-BC1A-826F8D54DAA9Q47157558-DF304FC5-8125-4867-A8A0-7F532012551BQ50965411-C1DCAD7D-AF04-4279-B72C-167A9D47D9D8Q51352618-24EC563C-D146-40F1-9217-0261D25C1265Q54349226-038FA17B-E6F8-46A2-800B-FF42E1ADEA75Q56554243-D6975C69-80A6-44B9-9A10-79005CB60693
P2860
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@ast
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@en
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@nl
type
label
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@ast
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@en
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@nl
prefLabel
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@ast
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@en
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@nl
P2093
P2860
P356
P1433
P1476
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
@en
P2093
Brandon G Bentz
Joel S Bentz
Leslie R Rowe
P2860
P356
10.1186/1742-6413-3-10
P577
2006-04-10T00:00:00Z